Go Pro
NASDAQ:WAY

Waystar (WAY) Stock Price, News & Analysis

Waystar logo
$21.11 0.00 (0.00%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$21.09 -0.02 (-0.09%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Waystar Stock (NASDAQ:WAY)

Advanced

Key Stats

Today's Range
$21.08
$22.33
50-Day Range
$17.31
$24.52
52-Week Range
$17.26
$41.47
Volume
3.86 million shs
Average Volume
2.71 million shs
Market Capitalization
$4.05 billion
P/E Ratio
30.16
Dividend Yield
N/A
Price Target
$35.14
Consensus Rating
Moderate Buy

Company Overview

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks. The platform’s functionality includes automated claim scrubbing, denial management, patient responsibility estimation, digital payment portals and electronic remittance processing. Robust analytics and reporting tools deliver real-time insights into revenue trends, enabling health systems and physician groups to identify bottlenecks, benchmark performance and drive targeted improvements.

Formed in 2018 through the merger of two established healthcare technology firms, Waystar combines decades of expertise in medical billing and revenue cycle services. Since its inception, the company has continued to invest in product innovation, expanding its platform to address emerging industry needs such as patient financial engagement, price transparency and value-based reimbursement models. Strategic partnerships with payers and technology vendors further enhance interoperability and data exchange capabilities.

Headquartered in the United States, Waystar serves a diverse customer base that spans hospitals, health systems and medical groups nationwide. By leveraging automation, interoperability and data-driven decision-making, the company empowers healthcare providers to navigate evolving regulatory requirements, adapt to changing payer policies and meet growing consumer expectations for digital payment experiences. Waystar’s solutions aim to simplify the revenue cycle and strengthen the financial resilience of its clients.

AI Generated. May Contain Errors.

Waystar Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
88th Percentile Overall Score

WAY MarketRank™: 

Waystar scored higher than 88% of companies evaluated by MarketBeat, and ranked 71st out of 894 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Waystar has received a consensus rating of Moderate Buy. The company's average rating score is 2.96, and is based on 3 strong buy ratings, 18 buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    Waystar has a consensus price target of $35.14, representing about 66.4% upside from its current price of $21.11.

  • Amount of Analyst Coverage

    Waystar has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Waystar's stock forecast and price target.
  • Earnings Growth

    Earnings for Waystar are expected to grow by 12.24% in the coming year, from $1.47 to $1.65 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Waystar is 30.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.98.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Waystar is 30.16, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 282.25.

  • Price to Earnings Growth Ratio

    Waystar has a PEG Ratio of 0.82. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Waystar has a P/B Ratio of 1.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    7.34% of the float of Waystar has been sold short.
  • Short Interest Ratio / Days to Cover

    Waystar has a short interest ratio ("days to cover") of 4.96.
  • Change versus previous month

    Short interest in Waystar has recently increased by 5.13%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Waystar does not currently pay a dividend.

  • Dividend Growth

    Waystar does not have a long track record of dividend growth.

  • News Sentiment

    Waystar has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Waystar this week, compared to 5 articles on an average week.
  • Search Interest

    7 people have searched for WAY on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 2 people have added Waystar to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Waystar insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    3.50% of the stock of Waystar is held by insiders.

  • Percentage Held by Institutions

    Waystar has minimal institutional ownership at this time.

  • Read more about Waystar's insider trading history.
Receive WAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Waystar and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

WAY Stock News Headlines

Needham & Company LLC Reiterates "Buy" Rating for Waystar (NASDAQ:WAY)
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
Waystar Reports Second Quarter 2026 Results
See More Headlines

WAY Stock Analysis - Frequently Asked Questions

Waystar's stock was trading at $32.75 at the beginning of 2026. Since then, WAY stock has decreased by 35.5% and is now trading at $21.11.

Waystar Holding Corp. (NASDAQ:WAY) issued its quarterly earnings data on Wednesday, July, 29th. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.03. Waystar's quarterly revenue was up 18.1% on a year-over-year basis.
Read the conference call transcript
.

Waystar (WAY) raised $968 million in an IPO on Friday, June 7th 2024. The company issued 45,000,000 shares at a price of $20.00-$23.00 per share.

Waystar's top institutional investors include Handelsbanken Fonder AB (0.02%), City Center Advisors LLC (0.01%), Central Pacific Bank Trust Division (0.01%) and GAMMA Investing LLC. Insiders that own company stock include Luxco SA RL Derby, Canada Pension Plan Investment, Paul G Moskowitz, Matthew J Hawkins, T Craig Bridge, Eric L (Ric) Sinclair III, Christopher L Schremser, Steven M Oreskovich and Melissa F (Missy) Miller.
View institutional ownership trends
.

Shares of WAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Waystar investors own include NVIDIA (NVDA), Broadcom (AVGO), Advanced Micro Devices (AMD), PayPal (PYPL), Oracle (ORCL), Pfizer (PFE) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
7/29/2026
Today
8/02/2026
Investor Day 2026
8/25/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
NASDAQ:WAY
Previous Symbol
NASDAQ:WAY
CIK
1990354
Web
N/A
Fax
N/A
Employees
1,700
Year Founded
2017

Price Target and Rating

High Price Target
$48.00
Low Price Target
$25.00
Potential Upside/Downside
+66.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.96
Research Coverage
24 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.70
Trailing P/E Ratio
30.16
Forward P/E Ratio
14.36
P/E Growth
0.82
Net Income
$112.09 million
Net Margins
11.18%
Pretax Margin
16.18%
Return on Equity
7.03%
Return on Assets
4.75%

Debt

Debt-to-Equity Ratio
0.36
Current Ratio
1.85
Quick Ratio
1.85

Sales & Book Value

Annual Sales
$1.10 billion
Price / Sales
3.68
Cash Flow
$1.95 per share
Price / Cash Flow
10.83
Book Value
$20.27 per share
Price / Book
1.04

Miscellaneous

Outstanding Shares
191,750,000
Free Float
185,037,000
Market Cap
$4.05 billion
Optionable
Optionable
Beta
0.06

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:WAY) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners